Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 July 2019 | Story Valentino Ndaba | Photo Valentino Ndaba
Dr Lazlo Passemiers
Dr Lazlo Passemiers spent six years conducting research across three continents.

A keen interest in unravelling transnational histories of 20th-century Southern Africa led Postdoctoral Research Fellow Dr Lazlo Passemiers to spend six years conducting extensive research across three continents. Dr Passemiers sifted through archives in Africa, Europe, and the US in order to convert his PhD thesis into a monograph.

It was on 17 July 2019 that the fruits of Passemiers’ labour were officially launched by the International Studies Group at the University of the Free State’s Bloemfontein Campus. His book, Decolonisation and Regional Geopolitics: South Africa and the ‘Congo Crisis’, 1960-1965, offers an important shift in the historiography of the Congo Crisis. It creatively centres African involvement in the debate by examining this event from a regional geopolitical angle. 

Going back in time 

By providing a three-fold perspective that examines decolonisation, apartheid diplomacy, and Southern African nationalist movements, the book offers a rounded picture of South African involvement in the Congo Crisis.

Dr Passemiers’ fascination with the transnational dynamics of Southern Africa’s history has rippled into two new research projects that respectively explore “the connection between decolonisation and white flight in the region as well as the transnational support networks of liberation movements”.

Finding the missing pieces of the puzzle

Prof Christopher Saunders, Emeritus Professor at the University of Cape Town, commended Dr Passemiers’ historiographical contribution: “He has identified a major gap in the literature and he has filled it admirably by looking across the spectrum.” As Prof Saunders noted, “what has been missing in the literature is the African angle.” 

Literature’s role in transformation

The process of undoing the profound impact of colonialism on society is long and difficult and important in this process is a clear understanding of history, which Dr Passemiers’ book enhances.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept